FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366992949> ?p ?o ?g. }

• W4366992949 abstract "Hypertension (HTN) is the most frequent adverse event during treatment with lenvatinib (LEN), but data on its best management are limited.The objective of this study was to assess incidence, features and best management of LEN-related HTN in a consecutive single tertiary-care centre cohort.Twenty-nine patients were followed up for a mean time of 29.8 months (6-77 months).After a mean follow-up of 6.8 months, HTN was recorded in 76% of cases, as a de novo occurrence in half of them. HTN significantly correlated with LEN dose and was of grade 1, grade 2 and grade 3 in 5%, 50% and 45% of patients, respectively. The majority (77%) of patients with HTN developed proteinuria. There was no correlation between HTN and proteinuria or clinical features or best morphological response or any other adverse event (AE), with the exception of diarrhoea. Patients with or without pre-existing HTN or any other cardiovascular disease had a similar incidence of HTN during LEN, thus excluding the impact of this potential predisposing factor. After evaluation by a dedicated cardiologist, medical treatment was introduced in 21/22 patients (polytherapy in 20 of them). The most frequently used drugs were calcium channel blockers (CCBs) due to their effect on vasodilation. In case of poor control, CCBs were associated with one or more anti-hypertensive drug.HTN is a frequent and early AE in patients on LEN treatment. We suggest a diagnostic and therapeutic algorithm to be applied in clinical practice to allow efficient HTN control and improve patient compliance, reducing LEN discontinuation." @default.
• W4366992949 created "2023-04-27" @default.
• W4366992949 creator A5007505317 @default.
• W4366992949 creator A5010811045 @default.
• W4366992949 creator A5042764318 @default.
• W4366992949 creator A5050819675 @default.
• W4366992949 creator A5053326821 @default.
• W4366992949 creator A5055208154 @default.
• W4366992949 creator A5067018248 @default.
• W4366992949 creator A5067250875 @default.
• W4366992949 creator A5077613101 @default.
• W4366992949 creator A5089949559 @default.
• W4366992949 date "2023-04-25" @default.
• W4366992949 modified "2023-09-30" @default.
• W4366992949 title "Management of hypertension during lenvatinib for advanced thyroid cancer: a suggested diagnostic and therapeutic algorithm" @default.
• W4366992949 cites W1594241115 @default.
• W4366992949 cites W1967792499 @default.
• W4366992949 cites W2019607817 @default.
• W4366992949 cites W2068644298 @default.
• W4366992949 cites W2119501407 @default.
• W4366992949 cites W2122956665 @default.
• W4366992949 cites W2145150141 @default.
• W4366992949 cites W2168076926 @default.
• W4366992949 cites W2597211357 @default.
• W4366992949 cites W2735430493 @default.
• W4366992949 cites W2749674352 @default.
• W4366992949 cites W2766426751 @default.
• W4366992949 cites W2777197634 @default.
• W4366992949 cites W2778164077 @default.
• W4366992949 cites W2789109497 @default.
• W4366992949 cites W2799673355 @default.
• W4366992949 cites W2801111216 @default.
• W4366992949 cites W2811375847 @default.
• W4366992949 cites W2905726151 @default.
• W4366992949 cites W2945004896 @default.
• W4366992949 cites W2949133444 @default.
• W4366992949 cites W2958835124 @default.
• W4366992949 cites W2966757906 @default.
• W4366992949 cites W2976988657 @default.
• W4366992949 cites W2990423583 @default.
• W4366992949 cites W2996749329 @default.
• W4366992949 cites W2999089687 @default.
• W4366992949 cites W3015023711 @default.
• W4366992949 cites W3080978633 @default.
• W4366992949 cites W3083074269 @default.
• W4366992949 cites W3178183483 @default.
• W4366992949 cites W3205433234 @default.
• W4366992949 cites W3209890625 @default.
• W4366992949 cites W3215308582 @default.
• W4366992949 cites W4200625020 @default.
• W4366992949 cites W4283796713 @default.
• W4366992949 cites W939443852 @default.
• W4366992949 doi "https://doi.org/10.1530/etj-23-0047" @default.
• W4366992949 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37097040" @default.
• W4366992949 hasPublicationYear "2023" @default.
• W4366992949 type Work @default.
• W4366992949 citedByCount "1" @default.
• W4366992949 countsByYear W43669929492023 @default.
• W4366992949 crossrefType "journal-article" @default.
• W4366992949 hasAuthorship W4366992949A5007505317 @default.
• W4366992949 hasAuthorship W4366992949A5010811045 @default.
• W4366992949 hasAuthorship W4366992949A5042764318 @default.
• W4366992949 hasAuthorship W4366992949A5050819675 @default.
• W4366992949 hasAuthorship W4366992949A5053326821 @default.
• W4366992949 hasAuthorship W4366992949A5055208154 @default.
• W4366992949 hasAuthorship W4366992949A5067018248 @default.
• W4366992949 hasAuthorship W4366992949A5067250875 @default.
• W4366992949 hasAuthorship W4366992949A5077613101 @default.
• W4366992949 hasAuthorship W4366992949A5089949559 @default.
• W4366992949 hasBestOaLocation W43669929491 @default.
• W4366992949 hasConcept C11413529 @default.
• W4366992949 hasConcept C120665830 @default.
• W4366992949 hasConcept C121332964 @default.
• W4366992949 hasConcept C121608353 @default.
• W4366992949 hasConcept C126322002 @default.
• W4366992949 hasConcept C187212893 @default.
• W4366992949 hasConcept C197934379 @default.
• W4366992949 hasConcept C2776264508 @default.
• W4366992949 hasConcept C2779134260 @default.
• W4366992949 hasConcept C2779561371 @default.
• W4366992949 hasConcept C2779761222 @default.
• W4366992949 hasConcept C2780091579 @default.
• W4366992949 hasConcept C41008148 @default.
• W4366992949 hasConcept C61511704 @default.
• W4366992949 hasConcept C71924100 @default.
• W4366992949 hasConcept C72563966 @default.
• W4366992949 hasConceptScore W4366992949C11413529 @default.
• W4366992949 hasConceptScore W4366992949C120665830 @default.
• W4366992949 hasConceptScore W4366992949C121332964 @default.
• W4366992949 hasConceptScore W4366992949C121608353 @default.
• W4366992949 hasConceptScore W4366992949C126322002 @default.
• W4366992949 hasConceptScore W4366992949C187212893 @default.
• W4366992949 hasConceptScore W4366992949C197934379 @default.
• W4366992949 hasConceptScore W4366992949C2776264508 @default.
• W4366992949 hasConceptScore W4366992949C2779134260 @default.
• W4366992949 hasConceptScore W4366992949C2779561371 @default.
• W4366992949 hasConceptScore W4366992949C2779761222 @default.
• W4366992949 hasConceptScore W4366992949C2780091579 @default.
• W4366992949 hasConceptScore W4366992949C41008148 @default.
• W4366992949 hasConceptScore W4366992949C61511704 @default.

• next